MAP2K7 and neoplasm: A plethora of studies has identified a role for MEK signalling in tumour cells as a mechanism for conferring chemoresistance, whereby attenuation of MEK signalling overcame chemoresistance in tumour types such as nasopharyngeal carcinoma, oral squamous cell carcinoma26,27 and breast cancer28.